Results 41 to 50 of about 698,336 (388)
Translational Oncology, 2017 BACKGROUND: The prognostic value of serum biomarkers in soft tissue sarcoma (STS) is limited, and its clinical applicability is compromised by a common inability to adjust for important confounders.
Katja Maretty-Kongstad +3 more
doaj +1 more source
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
npj Precision Oncology, 2021 Soft tissue sarcomas (STS) are rare and heterogeneous tumours comprising over 80 different histological subtypes. Treatment options remain limited in advanced STS with high rates of recurrence following resection of localised disease.
Eve Merry +3 more
doaj +1 more source
Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstruction. [PDF]
, 2012 Soft tissue sarcomas are uncommon tumors, and intraduodenal soft tissue sarcoma manifestation is even more rare. Only three cases of intraduodenal sarcomas have been reported in the literature thus far.
Bao, Jean J +5 more
core +1 more source
Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas. [PDF]
, 2020 BackgroundWhile racial/ethnic survival disparities have been described in pediatric oncology, the impact of income has not been extensively explored. We analyzed how public insurance influences 5-year overall survival (OS) in young patients with sarcomas.
Goldsby, Robert E +5 more
core +1 more source
Sarcomas, 2019 Ewing sarcoma is a cancerous tumor that occurs in bones or soft tissues, such as cartilage or nerves. There are several types of Ewing sarcoma, including Ewing sarcoma of bone, extraosseous Ewing sarcoma, peripheral primitive neuroectodermal tumor (pPNET)
W. Alperstein, M. Trucco
semanticscholar +1 more source
Definitions, 2020 Histiocytic sarcoma, a rare malignant neoplasm showing morphologic and immunophenotypic features of histiocytes, is characterized typically by extranodal presentation and a dismal clinical course, particularly in patients with disseminated disease.
Xiaohua Qian
semanticscholar +1 more source
Scientific Reports, 2017 Chondrosarcoma (CS) is a rare cancer, but it is the second most common primary malignant bone tumor and highly resistant to conventional chemotherapy and radiotherapy.
Pei Liu +4 more
doaj +1 more source
Intrapelvic melanocytic schwannoma resection with computer-assisted navigation
Radiology Case Reports, 2020 Melanocytic schwannoma is a rare nerve tumor characterized by melanin-producing neoplastic Schwann cells. Wide surgical resection is the management of choice for this tumor; however, anatomical location and proximity to nerve roots can make locating this
Caroline A. Gerhardt, BS +4 more
doaj +1 more source
GSK3-beta as a candidate therapeutic target in soft tissue sarcomas
Journal of Hematology & Oncology, 2021 Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown.
S. Verbeke +7 more
doaj +1 more source
The Epidemiology of Sarcoma [PDF]
Clinical Sarcoma Research, 2012 AbstractSarcomas account for over 20% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers. The vast majority of diagnosed sarcomas will be soft tissue sarcomas, while malignant bone tumors make up just over 10% of sarcomas. The risks for sarcoma are not well-understood.
Zachary Burningham +3 more
openaire +4 more sources